

Artificial Transcatheter Heart Valve Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
2031
Request Sample Report
The global Artificial Transcatheter Heart Valve market is experiencing significant growth due to the increasing prevalence of heart diseases and advancements in medical technology. Market research reports project a market size of $3.5 billion by 2027, driven by the rising demand for minimally invasive procedures and the aging population.
◍ Edwards Lifesciences
◍ Medtronic
◍ Abbott
◍ Livanova
◍ Boston Scientific
◍ Cryolife
The Artificial Transcatheter Heart Valve Market is highly competitive with key players such as Edwards Lifesciences, Medtronic, Abbott, Livanova, Boston Scientific, Cryolife, and others. These companies develop innovative technologies and solutions to address the growing demand for minimally invasive heart valve procedures, helping to expand the market. Below are the sales revenue figures for a few companies:
- Edwards Lifesciences: $4.3 billion
◍ Suzhou Jiecheng Medical Technology Co., Ltd.
◍ Labcor Laboratórios Ltda
◍ Braile Biomédica
◍ MicroPort Scientific Corporation
- Medtronic: $30.6 billion
- Abbott: $34.6 billion
◍ Beijing Balance Medical Technology Co., Ltd.
◍ Myval
Request Sample Report
Aortic Stenosis
Aortic Regurgitation
Others
◍ Aortic Heart Valve
Mitral Heart Valve
Tricuspid Heart Valve
Request Sample Report
Request Sample Report
$ 2.40 Billion